Startup | February 10, 2022
Basf, Orbia Ventures invest in Israeli biotech startup
FortePhest is developing a new technology to combat herbicide-resistant weeds and invasive plants
FortePhest is developing a new technology to combat herbicide-resistant weeds and invasive plants
It would be the first protein-based alternative available in Israel
Market authorization for generic GLP-1 therapy strengthens company’s diabetes portfolio in Canada
Dr Desai argued that the sector is undergoing a structural acceleration in how quickly science turns into treatments
The companies plan to advance multiple solid tumor targets from Regeneron’s antibody portfolio
The India FMCG business showed a sequential recovery and is expected to post high-single digit growth
The impact on Phase III trials is particularly significant, as these later-stage studies involve larger, committed patient populations and represent years of investment
The announcement marks Dr. Reddy’s Day?1 entry into the GLP?1 receptor agonists therapy space and readiness to serve patients in India
The approval of Cosentyx represents an important advancement for younger HS patients who have had limited treatment options
The conflict is also triggering a widening public health emergency
Subscribe To Our Newsletter & Stay Updated
